Pharmaceuticals

Evernorth to offer Stelara biosimilar at no copayment

bexib
By bexib 0 Min Read

This is the second biosimilar the company is offering to customers at this price point.

You Might Also Like

Pharma Pulse 8/6/24: The evolution of temperature-sensitive biologics, is it a bad thing that AI is taking over meaningless jobs?, and more

Yvonne Greenstreet: Answer the phone

Can Data and AI Enable Whole Person Health?

Eli Lilly and OpenAI sign collaboration agreement to discover new antibiotics to fight drug resistance

Months after Supreme Court’s landmark Chevron decision, pharmaceutical industry concerns grow

Share This Article
Previous Article Florida and Texas home price growth slows as inventory soars
Next Article First barter trade between Russia and China could begin this fall, sources say
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Rakkar secures digital asset custody license in Thailand
Fintech
OCBC Debuts Tokenized Bonds for Accredited Corporate Investors
Fintech
Auckland ranks 2nd in cat lover ranking!
Hospitality & Tourism
Mr. Rajat Verma will become CEO of DBS India in March 2025
Fintech